aluates Reports

$ 0.0

Automative

Global Genomic Testing in Cancer Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-37F13115

Global Genomic Testing in Cancer Market Research Report 2023

BUY CHAPTERS

Global Genomic Testing in Cancer Market Research Report 2024

Code: QYRE-Auto-37F13115

Report

April 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Bio Rad Laboratories

CENTOGENE

Color Genomics

Gene By Gene

Illumina Inc

LabCorp

Myriad Genetics

Positive Bioscience

Quest Diagnostics

Thermo Fisher Scientific

Genomic Testing in Cancer Market

The global Genomic Testing in Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Genomic Testing in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Genomic Testing in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Genomic Testing in Cancer in General Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Genomic Testing in Cancer include 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genomic Testing in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Testing in Cancer.

Report Scope

The Genomic Testing in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genomic Testing in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genomic Testing in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genomic Testing in Cancer Market Report

Report Metric	Details
Report Name	Genomic Testing in Cancer Market
Segment by Type	Breast Cancer Lung Cancer Blood Cancer Liver Cancer Stomach Cancer Others
Segment by Application	General Hospitals Specialty Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp, Myriad Genetics, Positive Bioscience, Quest Diagnostics, Thermo Fisher Scientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic Testing in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genomic Testing in Cancer Market report?

Ans: The main players in the Genomic Testing in Cancer Market are 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp, Myriad Genetics, Positive Bioscience, Quest Diagnostics, Thermo Fisher Scientific

What are the Application segmentation covered in the Genomic Testing in Cancer Market report?

Ans: The Applications covered in the Genomic Testing in Cancer Market report are General Hospitals, Specialty Clinics

What are the Type segmentation covered in the Genomic Testing in Cancer Market report?

Ans: The Types covered in the Genomic Testing in Cancer Market report are Breast Cancer, Lung Cancer, Blood Cancer, Liver Cancer, Stomach Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genomic Testing in Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Breast Cancer

1.2.3 Lung Cancer

1.2.4 Blood Cancer

1.2.5 Liver Cancer

1.2.6 Stomach Cancer

1.2.7 Others

1.3 Market by Application

1.3.1 Global Genomic Testing in Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 General Hospitals

1.3.3 Specialty Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genomic Testing in Cancer Market Perspective (2019-2030)

2.2 Genomic Testing in Cancer Growth Trends by Region

2.2.1 Global Genomic Testing in Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Genomic Testing in Cancer Historic Market Size by Region (2019-2024)

2.2.3 Genomic Testing in Cancer Forecasted Market Size by Region (2025-2030)

2.3 Genomic Testing in Cancer Market Dynamics

2.3.1 Genomic Testing in Cancer Industry Trends

2.3.2 Genomic Testing in Cancer Market Drivers

2.3.3 Genomic Testing in Cancer Market Challenges

2.3.4 Genomic Testing in Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genomic Testing in Cancer Players by Revenue

3.1.1 Global Top Genomic Testing in Cancer Players by Revenue (2019-2024)

3.1.2 Global Genomic Testing in Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Genomic Testing in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Genomic Testing in Cancer Revenue

3.4 Global Genomic Testing in Cancer Market Concentration Ratio

3.4.1 Global Genomic Testing in Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genomic Testing in Cancer Revenue in 2023

3.5 Genomic Testing in Cancer Key Players Head office and Area Served

3.6 Key Players Genomic Testing in Cancer Product Solution and Service

3.7 Date of Enter into Genomic Testing in Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Genomic Testing in Cancer Breakdown Data by Type

4.1 Global Genomic Testing in Cancer Historic Market Size by Type (2019-2024)

4.2 Global Genomic Testing in Cancer Forecasted Market Size by Type (2025-2030)

5 Genomic Testing in Cancer Breakdown Data by Application

5.1 Global Genomic Testing in Cancer Historic Market Size by Application (2019-2024)

5.2 Global Genomic Testing in Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Genomic Testing in Cancer Market Size (2019-2030)

6.2 North America Genomic Testing in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Genomic Testing in Cancer Market Size by Country (2019-2024)

6.4 North America Genomic Testing in Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genomic Testing in Cancer Market Size (2019-2030)

7.2 Europe Genomic Testing in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Genomic Testing in Cancer Market Size by Country (2019-2024)

7.4 Europe Genomic Testing in Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genomic Testing in Cancer Market Size (2019-2030)

8.2 Asia-Pacific Genomic Testing in Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Genomic Testing in Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific Genomic Testing in Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genomic Testing in Cancer Market Size (2019-2030)

9.2 Latin America Genomic Testing in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Genomic Testing in Cancer Market Size by Country (2019-2024)

9.4 Latin America Genomic Testing in Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genomic Testing in Cancer Market Size (2019-2030)

10.2 Middle East & Africa Genomic Testing in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Genomic Testing in Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa Genomic Testing in Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 23andMe

11.1.1 23andMe Company Detail

11.1.2 23andMe Business Overview

11.1.3 23andMe Genomic Testing in Cancer Introduction

11.1.4 23andMe Revenue in Genomic Testing in Cancer Business (2019-2024)

11.1.5 23andMe Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Genomic Testing in Cancer Introduction

11.2.4 Agilent Technologies Revenue in Genomic Testing in Cancer Business (2019-2024)

11.2.5 Agilent Technologies Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Detail

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Genomic Testing in Cancer Introduction

11.3.4 Bio-Rad Laboratories Revenue in Genomic Testing in Cancer Business (2019-2024)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Centogene

11.4.1 Centogene Company Detail

11.4.2 Centogene Business Overview

11.4.3 Centogene Genomic Testing in Cancer Introduction

11.4.4 Centogene Revenue in Genomic Testing in Cancer Business (2019-2024)

11.4.5 Centogene Recent Development

11.5 Color Genomics

11.5.1 Color Genomics Company Detail

11.5.2 Color Genomics Business Overview

11.5.3 Color Genomics Genomic Testing in Cancer Introduction

11.5.4 Color Genomics Revenue in Genomic Testing in Cancer Business (2019-2024)

11.5.5 Color Genomics Recent Development

11.6 Gene By Gene

11.6.1 Gene By Gene Company Detail

11.6.2 Gene By Gene Business Overview

11.6.3 Gene By Gene Genomic Testing in Cancer Introduction

11.6.4 Gene By Gene Revenue in Genomic Testing in Cancer Business (2019-2024)

11.6.5 Gene By Gene Recent Development

11.7 Illumina

11.7.1 Illumina Company Detail

11.7.2 Illumina Business Overview

11.7.3 Illumina Genomic Testing in Cancer Introduction

11.7.4 Illumina Revenue in Genomic Testing in Cancer Business (2019-2024)

11.7.5 Illumina Recent Development

11.8 LabCorp

11.8.1 LabCorp Company Detail

11.8.2 LabCorp Business Overview

11.8.3 LabCorp Genomic Testing in Cancer Introduction

11.8.4 LabCorp Revenue in Genomic Testing in Cancer Business (2019-2024)

11.8.5 LabCorp Recent Development

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Detail

11.9.2 Myriad Genetics Business Overview

11.9.3 Myriad Genetics Genomic Testing in Cancer Introduction

11.9.4 Myriad Genetics Revenue in Genomic Testing in Cancer Business (2019-2024)

11.9.5 Myriad Genetics Recent Development

11.10 Positive Bioscience

11.10.1 Positive Bioscience Company Detail

11.10.2 Positive Bioscience Business Overview

11.10.3 Positive Bioscience Genomic Testing in Cancer Introduction

11.10.4 Positive Bioscience Revenue in Genomic Testing in Cancer Business (2019-2024)

11.10.5 Positive Bioscience Recent Development

11.11 Quest Diagnostics

11.11.1 Quest Diagnostics Company Detail

11.11.2 Quest Diagnostics Business Overview

11.11.3 Quest Diagnostics Genomic Testing in Cancer Introduction

11.11.4 Quest Diagnostics Revenue in Genomic Testing in Cancer Business (2019-2024)

11.11.5 Quest Diagnostics Recent Development

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Detail

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Genomic Testing in Cancer Introduction

11.12.4 Thermo Fisher Scientific Revenue in Genomic Testing in Cancer Business (2019-2024)

11.12.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies

Bio Rad Laboratories

CENTOGENE

Color Genomics

Gene By Gene

Illumina Inc

LabCorp

Myriad Genetics

Positive Bioscience

Quest Diagnostics

Thermo Fisher Scientific

List of Tables

Table 1. Global Genomic Testing in Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Breast Cancer

Table 3. Key Players of Lung Cancer

Table 4. Key Players of Blood Cancer

Table 5. Key Players of Liver Cancer

Table 6. Key Players of Stomach Cancer

Table 7. Key Players of Others

Table 8. Global Genomic Testing in Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Genomic Testing in Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Genomic Testing in Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Genomic Testing in Cancer Market Share by Region (2019-2024)

Table 12. Global Genomic Testing in Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Genomic Testing in Cancer Market Share by Region (2025-2030)

Table 14. Genomic Testing in Cancer Market Trends

Table 15. Genomic Testing in Cancer Market Drivers

Table 16. Genomic Testing in Cancer Market Challenges

Table 17. Genomic Testing in Cancer Market Restraints

Table 18. Global Genomic Testing in Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Genomic Testing in Cancer Market Share by Players (2019-2024)

Table 20. Global Top Genomic Testing in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing in Cancer as of 2023)

Table 21. Ranking of Global Top Genomic Testing in Cancer Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Genomic Testing in Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Genomic Testing in Cancer Product Solution and Service

Table 25. Date of Enter into Genomic Testing in Cancer Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Genomic Testing in Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Genomic Testing in Cancer Revenue Market Share by Type (2019-2024)

Table 29. Global Genomic Testing in Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Genomic Testing in Cancer Revenue Market Share by Type (2025-2030)

Table 31. Global Genomic Testing in Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Genomic Testing in Cancer Revenue Market Share by Application (2019-2024)

Table 33. Global Genomic Testing in Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Genomic Testing in Cancer Revenue Market Share by Application (2025-2030)

Table 35. North America Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Genomic Testing in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Genomic Testing in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Genomic Testing in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Genomic Testing in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Genomic Testing in Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Genomic Testing in Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Genomic Testing in Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Genomic Testing in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Genomic Testing in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Genomic Testing in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Genomic Testing in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 50. 23andMe Company Detail

Table 51. 23andMe Business Overview

Table 52. 23andMe Genomic Testing in Cancer Product

Table 53. 23andMe Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 54. 23andMe Recent Development

Table 55. Agilent Technologies Company Detail

Table 56. Agilent Technologies Business Overview

Table 57. Agilent Technologies Genomic Testing in Cancer Product

Table 58. Agilent Technologies Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 59. Agilent Technologies Recent Development

Table 60. Bio-Rad Laboratories Company Detail

Table 61. Bio-Rad Laboratories Business Overview

Table 62. Bio-Rad Laboratories Genomic Testing in Cancer Product

Table 63. Bio-Rad Laboratories Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 64. Bio-Rad Laboratories Recent Development

Table 65. Centogene Company Detail

Table 66. Centogene Business Overview

Table 67. Centogene Genomic Testing in Cancer Product

Table 68. Centogene Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 69. Centogene Recent Development

Table 70. Color Genomics Company Detail

Table 71. Color Genomics Business Overview

Table 72. Color Genomics Genomic Testing in Cancer Product

Table 73. Color Genomics Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 74. Color Genomics Recent Development

Table 75. Gene By Gene Company Detail

Table 76. Gene By Gene Business Overview

Table 77. Gene By Gene Genomic Testing in Cancer Product

Table 78. Gene By Gene Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 79. Gene By Gene Recent Development

Table 80. Illumina Company Detail

Table 81. Illumina Business Overview

Table 82. Illumina Genomic Testing in Cancer Product

Table 83. Illumina Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 84. Illumina Recent Development

Table 85. LabCorp Company Detail

Table 86. LabCorp Business Overview

Table 87. LabCorp Genomic Testing in Cancer Product

Table 88. LabCorp Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 89. LabCorp Recent Development

Table 90. Myriad Genetics Company Detail

Table 91. Myriad Genetics Business Overview

Table 92. Myriad Genetics Genomic Testing in Cancer Product

Table 93. Myriad Genetics Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 94. Myriad Genetics Recent Development

Table 95. Positive Bioscience Company Detail

Table 96. Positive Bioscience Business Overview

Table 97. Positive Bioscience Genomic Testing in Cancer Product

Table 98. Positive Bioscience Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 99. Positive Bioscience Recent Development

Table 100. Quest Diagnostics Company Detail

Table 101. Quest Diagnostics Business Overview

Table 102. Quest Diagnostics Genomic Testing in Cancer Product

Table 103. Quest Diagnostics Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 104. Quest Diagnostics Recent Development

Table 105. Thermo Fisher Scientific Company Detail

Table 106. Thermo Fisher Scientific Business Overview

Table 107. Thermo Fisher Scientific Genomic Testing in Cancer Product

Table 108. Thermo Fisher Scientific Revenue in Genomic Testing in Cancer Business (2019-2024) & (US$ Million)

Table 109. Thermo Fisher Scientific Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Genomic Testing in Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Genomic Testing in Cancer Market Share by Type: 2023 VS 2030

Figure 3. Breast Cancer Features

Figure 4. Lung Cancer Features

Figure 5. Blood Cancer Features

Figure 6. Liver Cancer Features

Figure 7. Stomach Cancer Features

Figure 8. Others Features

Figure 9. Global Genomic Testing in Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Genomic Testing in Cancer Market Share by Application: 2023 VS 2030

Figure 11. General Hospitals Case Studies

Figure 12. Specialty Clinics Case Studies

Figure 13. Genomic Testing in Cancer Report Years Considered

Figure 14. Global Genomic Testing in Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Genomic Testing in Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Genomic Testing in Cancer Market Share by Region: 2023 VS 2030

Figure 17. Global Genomic Testing in Cancer Market Share by Players in 2023

Figure 18. Global Top Genomic Testing in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing in Cancer as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Genomic Testing in Cancer Revenue in 2023

Figure 20. North America Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Genomic Testing in Cancer Market Share by Country (2019-2030)

Figure 22. United States Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Genomic Testing in Cancer Market Share by Country (2019-2030)

Figure 26. Germany Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Genomic Testing in Cancer Market Share by Region (2019-2030)

Figure 34. China Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Genomic Testing in Cancer Market Share by Country (2019-2030)

Figure 42. Mexico Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Genomic Testing in Cancer Market Share by Country (2019-2030)

Figure 46. Turkey Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Genomic Testing in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. 23andMe Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 49. Agilent Technologies Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 51. Centogene Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 52. Color Genomics Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 53. Gene By Gene Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 54. Illumina Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 55. LabCorp Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 56. Myriad Genetics Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 57. Positive Bioscience Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 58. Quest Diagnostics Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Genomic Testing in Cancer Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lung Cancer Genomic Testing Market Research Report 2024

Global Next Generation Tumor Genetic Testing Market Research Report 2024

Global Genomic Biomarkers Market Research Report 2024

Global Cancer Oncology Testing Market Research Report 2024

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

Global Inherited Cancer Genome Testing Market Research Report 2024

Global Predictive Genetic Testing And Consumer Genomics Market Research Report 2024

Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Biomarker Test Market Research Report 2024

Global Genotyping Test Market Research Report 2025

Global Genomics Services Market Research Report 2024

Global Tumor Gene Test Service Market Research Report 2025

Global DNA Genetic Testing Market Research Report 2024

Cancer Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Genome Sequencing Market Research Report 2024

Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Screening Technology Market Research Report 2024

Next Generation Cancer Diagnostics Market

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions